Search Results - "Poznansky, Mark"
-
1
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Published in Cell (03-02-2022)“…Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of…”
Get full text
Journal Article -
2
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Published in Pharmacological research (01-09-2020)“…[Display omitted] AMD3100 (plerixafor), a CXCR4 antagonist, has opened a variety of avenues for potential therapeutic approaches in different refractory…”
Get full text
Journal Article -
3
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Published in Cell (29-04-2021)“…Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants…”
Get full text
Journal Article -
4
Dual blockade of CXCL12‐CXCR4 and PD‐1–PD‐L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the tumor microenvironment
Published in The FASEB journal (01-05-2019)“…ABSTRACTBlockade of immune‐checkpoint programmed cell death protein 1 (PD‐1) or programmed cell death ligand 1 can enhance effector T‐cell responses. However,…”
Get full text
Journal Article -
5
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Published in Proceedings of the National Academy of Sciences - PNAS (23-10-2012)“…The recent approval of a prostate cancer vaccine has renewed hope for anticancer immunotherapies. However, the immunosuppressive tumor microenvironment may…”
Get full text
Journal Article -
6
A HABA dye-based colorimetric assay to detect unoccupied biotin binding sites in an avidin-containing fusion protein
Published in BioTechniques (13-09-2024)“…Avidin-biotin binding, the most robust non-covalent protein-ligand interaction occurring in nature, has wide-ranging applications in biotechnology. A frequent…”
Get full text
Journal Article -
7
Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Published in The FASEB journal (01-05-2020)“…There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐19). Early anecdotal reports and limited in vitro data led to the…”
Get full text
Journal Article -
8
Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma
Published in International journal of radiation oncology, biology, physics (15-03-2022)“…To develop a comprehensive framework to simulate the response to immune checkpoint inhibitors (ICIs) in combination with radiation therapy (RT) and to apply…”
Get full text
Journal Article -
9
Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy
Published in Trends in molecular medicine (01-08-2024)“…Immunomodulatory drugs (IMiDs) are well-established anticancer agents for the treatment of haematological malignancies, in particular multiple myeloma…”
Get full text
Journal Article -
10
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
Published in Cancer cell (08-08-2022)“…Cellular deconvolution algorithms virtually reconstruct tissue composition by analyzing the gene expression of complex tissues. We present the decision tree…”
Get full text
Journal Article -
11
Standardized guinea pig model for Q fever vaccine reactogenicity
Published in PloS one (12-10-2018)“…Historically, vaccination with Coxiella burnetii whole cell vaccines has induced hypersensitivity reactions in humans and animals that have had prior exposure…”
Get full text
Journal Article -
12
Targeting metabolic pathways to counter cancer immunotherapy resistance
Published in Trends in immunology (01-07-2024)“…Metabolic modifiers can be efficacious in improving immune cell infiltration for various immunotherapeutic approaches, including immune checkpoint inhibitors,…”
Get full text
Journal Article -
13
Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
Published in Cancer research (Chicago, Ill.) (15-07-2018)“…The mechanism by which osteosarcomas metastasize is elusive, and challenges remain regarding its treatment with modalities including immunotherapy. CXCL12 is…”
Get full text
Journal Article -
14
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
Published in The Journal of infectious diseases (01-04-2022)“…Abstract Background Understanding immunogenicity and effectiveness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical to…”
Get full text
Journal Article -
15
Alginate‐microencapsulation of human stem cell–derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression
Published in American journal of transplantation (01-07-2019)“…Pancreatic β‐cell replacement by islet transplantation for the treatment of type 1 diabetes (T1D) is currently limited by donor tissue scarcity and the…”
Get full text
Journal Article -
16
Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions
Published in Wound repair and regeneration (01-09-2017)“…Chronic wounds affect 12–15% of patients with diabetes and are associated with a drastic decrease in their quality of life. Here, we demonstrate that purified…”
Get full text
Journal Article -
17
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
Published in The Journal of infectious diseases (15-12-2020)“…Abstract SARS-CoV-2 antibody testing allows quantitative determination of disease prevalence, which is especially important in high-risk communities. We…”
Get full text
Journal Article -
18
B cell treatment promotes a neuroprotective microenvironment after traumatic brain injury through reciprocal immunomodulation with infiltrating peripheral myeloid cells
Published in Journal of neuroinflammation (31-05-2023)“…Traumatic brain injury (TBI) remains a major cause of death and severe disability worldwide. We found previously that treatment with exogenous naïve B cells…”
Get full text
Journal Article -
19
Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetes
Published in Pharmacology & therapeutics (Oxford) (01-01-2019)“…Type 1 diabetes (T1D) is a complex multifactorial disease characterized by autoimmune destruction of insulin-producing pancreatic β cells. Our understanding of…”
Get full text
Journal Article -
20
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Published in Cancer research (Chicago, Ill.) (15-08-2011)“…The chemokine CXCL12 and its receptor CXCR4 are expressed widely in human cancers, including ovarian cancer, in which they are associated with disease…”
Get full text
Journal Article